71 related articles for article (PubMed ID: 6540144)
1. Chemotherapy for advanced epidermoid carcinoma of the esophagus with single-agent cisplatin: final report on a Southwest Oncology Group study.
Panettiere FJ; Leichman LP; Tilchen EJ; Chen TT
Cancer Treat Rep; 1984; 68(7-8):1023-4. PubMed ID: 6540144
[No Abstract] [Full Text] [Related]
2. Cis-diamminedichloride platinum(II), an effective agent in the treatment of epidermoid carcinoma of the esophagus. A preliminary report of an ongoing Southwest Oncology Group study.
Panettiere FJ; Leichman L; O'Bryan R; Haas C; Fletcher W
Cancer Clin Trials; 1981; 4(1):29-31. PubMed ID: 7194161
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
4. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma. A multicentre randomised controlled trial. The French Associations for Surgical Research.
Levard H; Pouliquen X; Hay JM; Fingerhut A; Langlois-Zantain O; Huguier M; Lozach P; Testart J
Eur J Surg; 1998 Nov; 164(11):849-57. PubMed ID: 9845131
[TBL] [Abstract][Full Text] [Related]
6. Phase II evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial.
Ravry MJ; Moore MR; Omura GA; Esseese I; Bartolucci A
Cancer Treat Rep; 1985 Dec; 69(12):1457-8. PubMed ID: 4075322
[No Abstract] [Full Text] [Related]
7. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
8. cis-Dichlorodiammineplatinum(II) in the treatment of esophageal carcinoma.
Davis S; Shanmugathasa M; Kessler W
Cancer Treat Rep; 1980; 64(4-5):709-11. PubMed ID: 7191780
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of single-agent cisplatin in the management of non-small cell carcinoma of the lung: a Southwest Oncology Group Study.
Panettiere FJ; Vance RB; Stuckey WJ; Coltman CA; Costanzi JJ; Chen TT
Cancer Treat Rep; 1983 Apr; 67(4):399-400. PubMed ID: 6682701
[No Abstract] [Full Text] [Related]
10. Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma.
Lin CC; Yeh KH; Yang CH; Hsu C; Tsai YC; Hsu WL; Cheng AL; Hsu CH
Anticancer Drugs; 2007 Jul; 18(6):703-8. PubMed ID: 17762400
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of neoadjuvant cisplatin, 5-fluorouracil and interferon-alpha in operable squamous cell carcinoma of the esophagus.
Bazarbashi S; Abdelsalam M; Amin T; El-Bassiouni M; Soudy H; Elweshi A; Alhusseiny H; Rehman K; Memon M; Ajarim D
Chemotherapy; 2008; 54(4):315-22. PubMed ID: 18701820
[TBL] [Abstract][Full Text] [Related]
12. Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma.
Engstrom PF; Lavin PT; Klaassen DJ
Cancer Treat Rep; 1983; 67(7-8):713-5. PubMed ID: 6683591
[No Abstract] [Full Text] [Related]
13. Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
Hsu CH; Yeh KH; Lui LT; Lee YC; Bu CF; Wang HP; Lin JT; Cheng AL
Anticancer Res; 1999; 19(5C):4463-7. PubMed ID: 10650793
[TBL] [Abstract][Full Text] [Related]
14. Sodium-wasting nephropathy caused by cisplatin in esophageal cancer.
Abdelghani L; Modha K; Albaddawi E; Subramanian S
J Support Oncol; 2008; 6(7):305-6. PubMed ID: 18847072
[No Abstract] [Full Text] [Related]
15. Management for patients with advanced T4 epidermoid carcinoma of the esophagus.
Wang LS; Chi KH; Hu MH; Fahn HJ; Huang MH
J Surg Oncol; 1996 May; 62(1):22-9. PubMed ID: 8618396
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the second cycle response to cisplatin-based chemotherapy as preoperative treatment for esophageal squamous cell carcinoma.
Akita H; Doki Y; Miyata H; Hirao T; Yano M; Takachi K; Miyashiro I; Sasaki Y; Ishikawa O; Ohigashi H; Imaoka S
J Surg Oncol; 2006 Apr; 93(5):401-9. PubMed ID: 16550577
[TBL] [Abstract][Full Text] [Related]
17. [A case of esophageal carcinoma with liver metastasis treated with cisplatin].
Yoshii K; Suzuki S; Ide H; Anko H; Ota S; Arai M; Yamashita Y; Suguro M; Kitamura Y; Murata Y
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2216-21. PubMed ID: 4062321
[TBL] [Abstract][Full Text] [Related]
18. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
19. Clinical markers of hypoxia and other predictive factors of survival in conservative therapy of squamous-cell carcinoma of the esophagus.
Taussky D; Rousson V; Pescia R
Int J Colorectal Dis; 2003 Mar; 18(2):167-71. PubMed ID: 12548421
[TBL] [Abstract][Full Text] [Related]
20. [Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer. Multicenter phase II FFCD 8804 study].
Bedenne L; Seitz JF; Milan C; Renard P; Fraisse J; Conroy T; Lacourt J; Janoray P; Faivre J
Gastroenterol Clin Biol; 1998 Mar; 22(3):273-81. PubMed ID: 9762210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
